Literature DB >> 20637618

Using mouse cranial muscles to investigate neuromuscular pathology in vivo.

L M Murray1, T H Gillingwater, S H Parson.   

Abstract

Neuromuscular pathology is a classic hallmark of many diseases such as muscular dystrophy, myasthenia gravis, amyotrophic lateral sclerosis and spinal muscular atrophy. It is also a feature of many congenital and acquired myopathies and neuropathies such as diabetic neuropathy and toxin-exposure. The availability of experimentally accessible nerve-muscle preparations from rodent models in which pathological events can be studied in nerve and muscle, as well as at the neuromuscular junction, is therefore of fundamental importance for investigating neuromuscular disease. The group of small cranial muscles, which move the ear in the mouse provide ideal experimental preparations for the study of neuromuscular disease in vivo, but information regarding their anatomical and functional characteristics is currently lacking. Here, we provide a detailed description of the levator auris longus, auricularis superior, abductor auris longus and interscutularis muscles. In addition, we briefly review their differential fibre type and developmental characteristics, which can be exploited to aid our understanding of neuromuscular vulnerability and to provide preferable alternatives to more traditional muscle preparations such as gastrocnemius, soleus and diaphragm.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20637618     DOI: 10.1016/j.nmd.2010.06.013

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  14 in total

1.  Subcutaneous administration of muscarinic antagonists and triple-immunostaining of the levator auris longus muscle in mice.

Authors:  Megan Wright; Amy Kim; Young-Jin Son
Journal:  J Vis Exp       Date:  2011-09-08       Impact factor: 1.355

2.  NCALD Antisense Oligonucleotide Therapy in Addition to Nusinersen further Ameliorates Spinal Muscular Atrophy in Mice.

Authors:  Laura Torres-Benito; Svenja Schneider; Roman Rombo; Karen K Ling; Vanessa Grysko; Aaradhita Upadhyay; Natalia L Kononenko; Frank Rigo; C Frank Bennett; Brunhilde Wirth
Journal:  Am J Hum Genet       Date:  2019-06-20       Impact factor: 11.025

3.  Dissection of the transversus abdominis muscle for whole-mount neuromuscular junction analysis.

Authors:  Lyndsay Murray; Thomas H Gillingwater; Rashmi Kothary
Journal:  J Vis Exp       Date:  2014-01-11       Impact factor: 1.355

4.  Motor unit recovery following Smn restoration in mouse models of spinal muscular atrophy.

Authors:  Laura H Comley; Rachel A Kline; Alison K Thomson; Victoria Woschitz; Eric Villalón Landeros; Erkan Y Osman; Christian L Lorson; Lyndsay M Murray
Journal:  Hum Mol Genet       Date:  2022-09-10       Impact factor: 5.121

5.  Induction of cell stress in neurons from transgenic mice expressing yellow fluorescent protein: implications for neurodegeneration research.

Authors:  Laura H Comley; Thomas M Wishart; Becki Baxter; Lyndsay M Murray; Ailish Nimmo; Derek Thomson; Simon H Parson; Thomas H Gillingwater
Journal:  PLoS One       Date:  2011-03-08       Impact factor: 3.240

6.  Morphological analysis of neuromuscular junction development and degeneration in rodent lumbrical muscles.

Authors:  James N Sleigh; Robert W Burgess; Thomas H Gillingwater; M Zameel Cader
Journal:  J Neurosci Methods       Date:  2014-02-14       Impact factor: 2.390

7.  NMJ-Analyser identifies subtle early changes in mouse models of neuromuscular disease.

Authors:  Elizabeth M C Fisher; Carole H Sudre; Alan Mejia Maza; Seth Jarvis; Weaverly Colleen Lee; Thomas J Cunningham; Giampietro Schiavo; Maria Secrier; Pietro Fratta; James N Sleigh
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.379

8.  Morphological characteristics of motor neurons do not determine their relative susceptibility to degeneration in a mouse model of severe spinal muscular atrophy.

Authors:  Sophie R Thomson; Joya E Nahon; Chantal A Mutsaers; Derek Thomson; Gillian Hamilton; Simon H Parson; Thomas H Gillingwater
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

9.  Label-free proteomics identifies Calreticulin and GRP75/Mortalin as peripherally accessible protein biomarkers for spinal muscular atrophy.

Authors:  Chantal A Mutsaers; Douglas J Lamont; Gillian Hunter; Thomas M Wishart; Thomas H Gillingwater
Journal:  Genome Med       Date:  2013-10-18       Impact factor: 11.117

10.  In vivo injection of α-bungarotoxin to improve the efficiency of motor endplate labeling.

Authors:  Wentao Chen; Tingting Yu; Bo Chen; Yisong Qi; Peixun Zhang; Dan Zhu; Xiaofeng Yin; Baoguo Jiang
Journal:  Brain Behav       Date:  2016-04-27       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.